| 國家衛生研究院 |
2005-08-01 |
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein
|
Yang, CH; Huang, CJ; Yang, CS; Chu, YC; Cheng, AL; Whang-Peng, J; Yang, PC |
| 國立臺灣大學 |
2005 |
Gefitinib Reverses Chemotherapy Resistance in Gefitinib-Insensitive Multidrug Resistant Cancer Cells Expressing Atp-Binding Cassette Family Protein
|
楊志新; 黃靜如; 楊朝順; 朱玉娟; 鄭安理; 彭汪嘉康; 楊泮池; YANG, CHIH-HSIN; HUANG, CHING-JU; YANG, CHAO-SHUN; CHU, YU-CHUAN; CHENG, ANN-LII; WHANG-PENG, JACQUELINE; YANG, PAN-CHYR |
| 臺大學術典藏 |
2020-05-26T09:27:28Z |
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein
|
Chih-Hsin Yang;Huang C.-J;Yang C.-S;Chu Y.-C;Cheng A.-L;Whang-Peng J;Yang P.-C.; CHIH-HSIN YANG; Huang C.-J; Yang C.-S; Chu Y.-C; Cheng A.-L; Whang-Peng J; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:35:41Z |
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein
|
Yang C.-H.;Huang C.-J.;Yang C.-S.;Chu Y.-C.;Cheng A.-L.;Whang-Peng J.;Pan-Chyr Yang; Yang C.-H.; Huang C.-J.; Yang C.-S.; Chu Y.-C.; Cheng A.-L.; Whang-Peng J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-09-01T02:02:17Z |
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein
|
Yang C.-H.; Huang C.-J.; Yang C.-S.; Chu Y.-C.; ANN-LII CHENG; Whang-Peng J.; Yang P.-C. |
| 臺大學術典藏 |
2018-09-10T08:28:52Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu, J.-Y. and Shih, J.-Y. and Chen, K.-Y. and Yang, C.-H. and Yu, C.-J. and Yang, P.-C.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-26T09:27:12Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y;Shih J.-Y;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T06:35:23Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Yang P.-C.; Wu J.-Y.;Shih J.-Y.;Chen K.-Y.;Yang C.-H.;Chong-Jen Yu;Yang P.-C.; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-13T06:33:53Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Chen K.-Y.;Yang C.-H.;Yu C.-J.;Yang P.-C.; Yang P.-C.; JIN-YUAN SHIH; Chen K.-Y.; Yang C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-12-02T02:34:10Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-04-29T02:38:41Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Anonymous |
| 臺大學術典藏 |
2021-04-29T05:09:12Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y.; Shih J.-Y.; KUAN-YU CHEN; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:07:36Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C. |
| 臺大學術典藏 |
2022-08-19T00:21:13Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Shih J.-Y.; CHIUN HSU; Yang P.-C.; Su W.-P.; Yang C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2018-09-10T05:11:38Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su, W.-P. and Yang, C.-H. and Yu, C.-J. and Shih, J.-Y. and Hsu, C. and Yang, P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-04-10T12:51:27Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.;Yang C.-H.;Yu C.-J.;Shih J.-Y.;Chiun Hsu;Yang P.-C.; Su W.-P.; Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chiun Hsu; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P;Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Hsu C;Yang P.-C.; Su W.-P; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Hsu C; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:06Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.; Yang C.-H.; Yu C.-J.; JIN-YUAN SHIH; Hsu C.; Yang P.-C.; Su W.-P.;Yang C.-H.;Yu C.-J.;Jin-Yuan Shih;Hsu C.;Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T06:35:50Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.;Yang C.-H.;Chong-Jen Yu;Shih J.-Y.;Hsu C.;Yang P.-C.; Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:35:37Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.;Yang C.-H.;Yu C.-J.;Shih J.-Y.;Hsu C.;Pan-Chyr Yang; Su W.-P.; Yang C.-H.; Yu C.-J.; Shih J.-Y.; Hsu C.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-06-27T07:06:37Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C. |
| 國立臺灣大學 |
2005 |
Gefitinib Treatment for Non-Small Cell Lung Cancer-a Study Including Patients with Poor Performance Status
|
蘇文彬; 楊志新; 余忠仁; 楊泮池; 施金元; 許駿; 楊志新; SU, WEN-PIN; YANG, CHIH-HSIN; YU, CHONG-JEN; YANG, PAN-CHYR; SHIH, JIN-YUAN; HSU, CHIUN |
| 國立臺灣大學 |
2011 |
Gefitinib-Induced Epidermal Growth Factor Receptor-Independent Keratinocyte Apoptosis Is Mediated by the Jnk Activation Pathway
|
呂柏萱; 朱家瑜; LU, PO-HSUAN; CHU, CHIA-YU |
| 臺大學術典藏 |
2019-12-04T08:43:54Z |
Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK activation pathway
|
Kuo T.-C.; Chang K.-C.; Chang C.-H.; CHIA-YU CHU; Lu P.-H.; Lu P.-H. ;Kuo T.-C. ;Chang K.-C. ;Chang C.-H. ;Chia-Yu Chu |
| 臺大學術典藏 |
2022-06-27T07:02:03Z |
Gefitinib-related interstitial lung disease in Taiwanese patients with non-small-cell lung cancer
|
Chang S.-C.; Chang C.-Y.; Chang S.-J.; Yuan M.-K.; Lai Y.-C.; Liu Y.-C.; Chen C.-Y.; Kuo L.-C.; CHONG-JEN YU |
